You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
McKesson
McKinsey
Colorcon
Merck

Last Updated: January 18, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Antipyrine

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Antipyrine?

Antipyrine is an investigational drug.

There have been 5 clinical trials for Antipyrine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2011.

The most common disease conditions in clinical trials are Gonadal Dysgenesis, Otitis Media, and HIV Infections. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Global United Pharmaceutical Corporation, and Pernix Theraputics LLC.

There are two US patents protecting this investigational drug and twenty-eight international patents.

Recent Clinical Trials for Antipyrine
TitleSponsorPhase
Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic AdultsGlobal United Pharmaceutical CorporationPhase 2
Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis MediaPernix Theraputics LLCPhase 2
Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)Merck Sharp & Dohme Corp.Phase 3

See all Antipyrine clinical trials

Clinical Trial Summary for Antipyrine

Top disease conditions for Antipyrine
Top clinical trial sponsors for Antipyrine

See all Antipyrine clinical trials

US Patents for Antipyrine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Antipyrine   Start Trial Pyrazole P38 map kinase inhibitors Respivert Limited (Buckinghamshire, GB)   Start Trial
Antipyrine   Start Trial Polymer electrolyte membrane, membrane-electrode assembly comprising the same and fuel cell comprising the same KOLON INDUSTRIES, INC. (Gwacheon-si, KR)   Start Trial
Antipyrine   Start Trial 2,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors 4SC AG (Planegg-Martinsried, DE)   Start Trial
Antipyrine   Start Trial Fast dissolving solid detergent Ecolab USA Inc. (St. Paul, MN)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Antipyrine

Drugname Country Document Number Estimated Expiration Related US Patent
Antipyrine European Patent Office EP2556065 2030-04-01   Start Trial
Antipyrine Spain ES2532764 2030-04-01   Start Trial
Antipyrine United Kingdom GB201005589 2030-04-01   Start Trial
Antipyrine Japan JP2013523710 2030-04-01   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
McKesson
McKinsey
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.